BRIEF-Helsinn Group and MEI Pharma’s Pracinostat receives orphan drug designation from European Medicines Agency


Jan 11 (Reuters) – Mei Pharma Inc:

* HELSINN GROUP AND MEI PHARMA ANNOUNCE THAT PRACINOSTAT HAS RECEIVED ORPHAN DRUG DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) Source text for Eikon: Further company coverage:


Read First From Source http://feeds.reuters.com/~r/reuters/companyNews/~3/oMy_4_rcvKI/brief-helsinn-group-and-mei-pharmas-pracinostat-receives-orphan-drug-designation-from-european-medicines-agency-idUSFWN1P6062

Learn More about Forex Signals

What do you think?

0 points
Upvote Downvote

Total votes: 0

Upvotes: 0

Upvotes percentage: 0.000000%

Downvotes: 0

Downvotes percentage: 0.000000%

Ultra Electronics sees ‘significant exposure’ to U.S. defense spending

BRIEF-CIMB, Principal Financial to realign ownership stakes in joint ventures